Article
Aβ-Overlapping Ectodomain Binding of the Clinical-Stage TREM2 Agonist VG-3927
2026-03-05
Abstract excerpt
Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial immune receptor genetically and functionally linked to Alzheimer’s disease (AD). VG-3927, the first clinical-stage small-molecule TREM2 agonist, has been proposed to function as a transmembrane molecular glue and positive allosteric modulator (PAM). Whether it directly engages the extracellular ligand-recognition surface of TREM2 remains unkn...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 98255c54-512a-5eba-b841-69a4169fc1eb
- DOI
- 10.64898/2026.03.02.709194
